milrinone has been researched along with Muscular Dystrophy, Duchenne in 2 studies
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We experienced a Duchenne muscular dystrophy (DMD) patient with severe congestive heart failure (CHF) successfully treated with milrinone." | 7.70 | [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure]. ( Kang, J; Matsumura, T; Miyai, I; Nozaki, S; Saito, T, 1999) |
| "We experienced a Duchenne muscular dystrophy (DMD) patient with severe congestive heart failure (CHF) successfully treated with milrinone." | 3.70 | [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure]. ( Kang, J; Matsumura, T; Miyai, I; Nozaki, S; Saito, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cripe, LH | 1 |
| Barber, BJ | 1 |
| Spicer, RL | 1 |
| Wong, BL | 1 |
| Weidner, N | 1 |
| Benson, DW | 1 |
| Markham, LW | 1 |
| Matsumura, T | 1 |
| Saito, T | 1 |
| Miyai, I | 1 |
| Nozaki, S | 1 |
| Kang, J | 1 |
2 other studies available for milrinone and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Disease Progression; Dobutamine; Dose-Response | 2006 |
[Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
Topics: Adult; Heart Failure; Humans; Male; Milrinone; Muscular Dystrophy, Duchenne; Phosphodiesterase Inhib | 1999 |